The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research Institute (OSUCCC - James) | Strategic Alliance Partners

Latest from The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research Institute (OSUCCC - James)

Dr. Bhat on the FDA Approval of Acalabrutinib in CLL

October 19, 2020

Video

Seema A. Bhat, MD, discusses the approval of acalabrutinib in chronic lymphocytic leukemia based on data from the phase 3 ELEVATE-TN trial.

Dr. Bhat on the Potential for Time-Limited Combinations in CLL

October 15, 2020

Video

Seema A. Bhat, MD, discusses the potential for time-limited combination regimens in chronic lymphocytic leukemia.

Targeted Therapies Take Center Stage in the CLL Treatment Paradigm

October 14, 2020

Article

Seema A. Bhat, MD, spotlights the advances that have been made with BTK inhibitors in chronic lymphocytic leukemia, shares emerging approaches under exploration, and forecasts where the field is headed.

Dr. Bhat on Emerging Targeted Therapies in CLL

October 14, 2020

Video

Seema A. Bhat, MD, emerging targeted therapies in chronic lymphocytic leukemia.

Dr. Bhat on the Rationale to Evaluate Acalabrutinib in CLL

October 12, 2020

Video

Seema A. Bhat, MD, discusses the rationale to evaluate acalabrutinib in chronic lymphocytic leukemia.

Dr. Bhat on the Combination of Ibrutinib Plus FCR in Treatment-Naïve CLL

October 05, 2020

Video

Seema A. Bhat, MD, discusses the combination of ibrutinib plus fludarabine, cyclophosphamide, and rituximab in young patients with treatment-naïve CLL.

Dr. Bhat on the Role of Targeted Therapies in CLL

October 02, 2020

Video

Seema A. Bhat, MD, hematologist, discusses the role of targeted therapies in chronic lymphocytic leukemia.

Dr. Maddocks on Ongoing Sequencing Challenges in DLBCL

September 23, 2020

Video

Kami J. Maddocks, MD, discusses ongoing sequencing challenges in diffuse large B-cell lymphoma.

Dr. Maddocks on Remaining Challenges in Follicular Lymphoma

September 22, 2020

Video

Kami J. Maddocks, MD, discusses remaining challenges in treating patients with follicular lymphoma.

Dr. Maddocks on Unanswered Questions With BTK Inhibitors in B-Cell Malignancies

September 16, 2020

Video

Kami J. Maddocks, MD, discusses unanswered questions with BTK inhibitors in B-cell malignancies.

Relapsed/Refractory DLBCL Paradigm Gains Chemotherapy-Free Option

September 15, 2020

Article

Kami J. Maddocks, MD, discusses the tolerability and promise of tafasitamab in combination with lenalidomide in relapsed or refractory DLBCL.

Dr. Woyach on Clinical Trials Examining Novel Triplets in CLL

September 14, 2020

Video

Jennifer Woyach, MD, discusses clinical trials examining novel triplet regimens in chronic lymphocytic leukemia.

Dr. Maddocks on the Role of Tazemetostat in EZH2-Mutant Follicular Lymphoma

September 14, 2020

Video

Kami J. Maddocks, MD, discusses the role of tazemetostat in patients with EZH2-mutant follicular lymphoma.

Dr. Woyach on the Safety of Acalabrutinib Versus Ibrutinib in CLL

September 11, 2020

Video

Jennifer Woyach, MD, discusses the safety profile of acalabrutinib compared with ibrutinib in chronic lymphocytic leukemia.

Dr. Woyach on the Role of Acalabrutinib in CLL

September 10, 2020

Video

Jennifer Woyach, MD, discusses the role of acalabrutinib in chronic lymphocytic leukemia.

BTK Inhibitors Boost Outcomes in B-Cell Malignancies, But Challenges Remain

September 10, 2020

Article

Kami J. Maddocks, MD, discusses the utility of BTK inhibitors in B-cell malignancies, challenges that are still faced in the space, and areas primed for additional development.